Past, present & the next frontier

Exosomes, new paradigm for
vital prevention and recuperative qualities

image

L’epigeneMDCOMPANY

A Bio-tech company that develops new global standard biopharmaceuticals based on exosome miRNA by adopting next-generation business model that expands and commercializes technology through collaboration with domestic and overseas research institutes.

View More

PLATFORM TECHNOLOGY

We’re creating the Next generation therapeutic using our patent pending platform technology.

The original technology to quantify and diagnose the complex biomarker derived from exosomes with the most
precise technology and to manufacture therapeutic substance using exosome gene.

View more

L’epigeneMD COMMUNITY